找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Artificial Oxygen Carrier; Its Frontline Koichi Kobayashi (Chief Professor of Surgery),Eish Conference proceedings 2005 Springer-Verlag Tok

[復制鏈接]
樓主: 聲音會爆炸
41#
發(fā)表于 2025-3-28 17:09:04 | 只看該作者
42#
發(fā)表于 2025-3-28 20:41:08 | 只看該作者
Isolation and Culture of Skin Fibroblastsing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
43#
發(fā)表于 2025-3-28 23:46:29 | 只看該作者
44#
發(fā)表于 2025-3-29 04:19:03 | 只看該作者
45#
發(fā)表于 2025-3-29 07:23:06 | 只看該作者
978-4-431-54636-8Springer-Verlag Tokyo 2005
46#
發(fā)表于 2025-3-29 12:24:26 | 只看該作者
Safety and Efficacy of Hemoglobin-Vesicles and Albumin-Hemes,s have been selected from the viewpoints of safety, efficacy, and cost performance. One is Hemoglobin-vesicles (HbV) and the other is albumin-heme (rHSA-heme). This chapter summarizes our video presentation that introduced the recent results of our research into HbV and rHSA-heme.
47#
發(fā)表于 2025-3-29 18:35:43 | 只看該作者
Hemoglobin-Vesicles (HbV) as Artificial Oxygen Carriers,ing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
48#
發(fā)表于 2025-3-29 22:17:19 | 只看該作者
Intravascular Microbubbles: An Ultra-Effective Means of Transporting Oxygen,able to transport physiologically significant amounts of oxygen in animal experiments. Thus, the treatment sustained life in rats and pigs with potentially fatal erythrocytopenia caused by hemorrhage and hemodilution, and adequate oxygenation was preserved in severe right-to-left circulatory shunts caused by partial airway blockage in pigs.
49#
發(fā)表于 2025-3-29 23:57:52 | 只看該作者
50#
發(fā)表于 2025-3-30 06:44:50 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-24 07:07
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
广水市| 大方县| 汝州市| 车险| 修文县| 囊谦县| 都昌县| 通许县| 沐川县| 新丰县| 遂川县| 金坛市| 竹北市| 张北县| 桦甸市| 菏泽市| 天峻县| 陆河县| 桦川县| 师宗县| 冀州市| 淮滨县| 土默特左旗| 潼南县| 平南县| 翼城县| 安远县| 尼玛县| 冷水江市| 黑水县| 宝应县| 龙陵县| 镇坪县| 神农架林区| 若尔盖县| 化州市| 揭西县| 永善县| 铜鼓县| 龙岩市| 方山县|